Global Nuclear Medicine Software Supply, Demand and Key Producers, 2026-2032
The global Nuclear Medicine Software market size is expected to reach $ 176 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).
Nuclear Medicine Software is a computer program system specifically designed for the entire workflow of nuclear medicine imaging, encompassing every stage from patient management and image acquisition to reconstruction, processing, analysis, and report generation. Its core task is to process the signals of radioactive tracer distribution within the body, captured by devices such as gamma cameras, SPECT, or PET scanners, and convert them into diagnostic anatomical-functional fusion images using specialized algorithms. This software not only provides quantitative analysis tools but also deeply integrates artificial intelligence technology to enhance image quality and assist in lesion detection and segmentation. As an intelligent hub connecting imaging equipment, hospital information systems, and clinical decision-making, nuclear medicine software is a key technological platform for improving diagnostic accuracy, optimizing workflows, and supporting cutting-edge research.
The costs of Nuclear Medicine Software primarily include substantial research and development investments (algorithm development, clinical validation), ongoing regulatory certification fees, and customer customization and technical support costs. Its gross profit margin is typically very high, reaching 70%-85% for standard products. This is mainly because its core value lies in intellectual property and software licenses; once developed, the marginal cost of replication is extremely low. The revenue model is primarily based on software licensing fees, annual maintenance fees, and fees charged per analysis module.
The current Nuclear Medicine Software market is undergoing a period of rapid growth and transformation driven by technological advancements. With the increasing adoption of PET/CT and PET/MR technologies and the emergence of new radiopharmaceuticals, the market is experiencing a surge in demand for precise quantitative analysis and multimodal fusion, driving the evolution of software from basic imaging tools to intelligent diagnostic platforms. The deep integration of artificial intelligence is a core trend, significantly improving image reconstruction quality and the efficiency and accuracy of automatic lesion detection and quantitative analysis. The market is dominated by international giants, but cloud-based SaaS models and third-party AI software companies are introducing new dimensions of competition. Simultaneously, driven by the development of precision medicine and integrated diagnosis and treatment, software applications are expanding into areas such as radiotherapy planning, neuroscience, and new drug development. Regulatory compliance and data security requirements are also becoming increasingly stringent, resulting in a market characterized by high added value and high technological barriers.
This report studies the global Nuclear Medicine Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Software total market, 2021-2032, (USD Million)
Global Nuclear Medicine Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine Software total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus, Mirion Medical, PAIRE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Software Market, By Region:
1. How big is the global Nuclear Medicine Software market?
2. What is the demand of the global Nuclear Medicine Software market?
3. What is the year over year growth of the global Nuclear Medicine Software market?
4. What is the total value of the global Nuclear Medicine Software market?
5. Who are the Major Players in the global Nuclear Medicine Software market?
6. What are the growth factors driving the market demand?
Nuclear Medicine Software is a computer program system specifically designed for the entire workflow of nuclear medicine imaging, encompassing every stage from patient management and image acquisition to reconstruction, processing, analysis, and report generation. Its core task is to process the signals of radioactive tracer distribution within the body, captured by devices such as gamma cameras, SPECT, or PET scanners, and convert them into diagnostic anatomical-functional fusion images using specialized algorithms. This software not only provides quantitative analysis tools but also deeply integrates artificial intelligence technology to enhance image quality and assist in lesion detection and segmentation. As an intelligent hub connecting imaging equipment, hospital information systems, and clinical decision-making, nuclear medicine software is a key technological platform for improving diagnostic accuracy, optimizing workflows, and supporting cutting-edge research.
The costs of Nuclear Medicine Software primarily include substantial research and development investments (algorithm development, clinical validation), ongoing regulatory certification fees, and customer customization and technical support costs. Its gross profit margin is typically very high, reaching 70%-85% for standard products. This is mainly because its core value lies in intellectual property and software licenses; once developed, the marginal cost of replication is extremely low. The revenue model is primarily based on software licensing fees, annual maintenance fees, and fees charged per analysis module.
The current Nuclear Medicine Software market is undergoing a period of rapid growth and transformation driven by technological advancements. With the increasing adoption of PET/CT and PET/MR technologies and the emergence of new radiopharmaceuticals, the market is experiencing a surge in demand for precise quantitative analysis and multimodal fusion, driving the evolution of software from basic imaging tools to intelligent diagnostic platforms. The deep integration of artificial intelligence is a core trend, significantly improving image reconstruction quality and the efficiency and accuracy of automatic lesion detection and quantitative analysis. The market is dominated by international giants, but cloud-based SaaS models and third-party AI software companies are introducing new dimensions of competition. Simultaneously, driven by the development of precision medicine and integrated diagnosis and treatment, software applications are expanding into areas such as radiotherapy planning, neuroscience, and new drug development. Regulatory compliance and data security requirements are also becoming increasingly stringent, resulting in a market characterized by high added value and high technological barriers.
This report studies the global Nuclear Medicine Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Software total market, 2021-2032, (USD Million)
Global Nuclear Medicine Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine Software total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus, Mirion Medical, PAIRE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Drug Management
- Radiation Management
- Other
- On Premise Software
- Cloud-Based Software
- Image Acquisition and Reconstruction Software
- Image Processing and Analysis Software
- Reporting and Information Management Software
- Others
- Clinical Diagnosis
- Research
- Others
- iQ IMAGE
- Mediso
- Segami
- Hermes Medical Solutions
- MIM Software Inc
- LabLogic
- scintido
- Gamma Gurus
- Mirion Medical
- PAIRE
- GE HealthCare
- Inter Medical
- Sirona
1. How big is the global Nuclear Medicine Software market?
2. What is the demand of the global Nuclear Medicine Software market?
3. What is the year over year growth of the global Nuclear Medicine Software market?
4. What is the total value of the global Nuclear Medicine Software market?
5. Who are the Major Players in the global Nuclear Medicine Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Medicine Software Introduction
1.2 World Nuclear Medicine Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nuclear Medicine Software Total Market by Region (by Headquarter Location)
1.3.1 World Nuclear Medicine Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.3 China Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.4 Europe Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.5 Japan Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.6 South Korea Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.8 India Based Company Nuclear Medicine Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Software Consumption Value (2021-2032)
2.2 World Nuclear Medicine Software Consumption Value by Region
2.2.1 World Nuclear Medicine Software Consumption Value by Region (2021-2026)
2.2.2 World Nuclear Medicine Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Software Consumption Value (2021-2032)
2.4 China Nuclear Medicine Software Consumption Value (2021-2032)
2.5 Europe Nuclear Medicine Software Consumption Value (2021-2032)
2.6 Japan Nuclear Medicine Software Consumption Value (2021-2032)
2.7 South Korea Nuclear Medicine Software Consumption Value (2021-2032)
2.8 ASEAN Nuclear Medicine Software Consumption Value (2021-2032)
2.9 India Nuclear Medicine Software Consumption Value (2021-2032)
3 WORLD NUCLEAR MEDICINE SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nuclear Medicine Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nuclear Medicine Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Nuclear Medicine Software in 2025
3.3 Nuclear Medicine Software Company Evaluation Quadrant
3.4 Nuclear Medicine Software Market: Overall Company Footprint Analysis
3.4.1 Nuclear Medicine Software Market: Region Footprint
3.4.2 Nuclear Medicine Software Market: Company Product Type Footprint
3.4.3 Nuclear Medicine Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nuclear Medicine Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nuclear Medicine Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nuclear Medicine Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nuclear Medicine Software Consumption Value Comparison
4.2.1 United States VS China: Nuclear Medicine Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nuclear Medicine Software Companies and Market Share, 2021-2026
4.3.1 United States Based Nuclear Medicine Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nuclear Medicine Software Revenue, (2021-2026)
4.4 China Based Companies Nuclear Medicine Software Revenue and Market Share, 2021-2026
4.4.1 China Based Nuclear Medicine Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nuclear Medicine Software Revenue, (2021-2026)
4.5 Rest of World Based Nuclear Medicine Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nuclear Medicine Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Drug Management
5.2.2 Radiation Management
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Software Market Size by Type (2021-2026)
5.3.2 World Nuclear Medicine Software Market Size by Type (2027-2032)
5.3.3 World Nuclear Medicine Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT
6.1 World Nuclear Medicine Software Market Size Overview by Deployment: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment
6.2.1 On Premise Software
6.2.2 Cloud-Based Software
6.3 Market Segment by Deployment
6.3.1 World Nuclear Medicine Software Market Size by Deployment (2021-2026)
6.3.2 World Nuclear Medicine Software Market Size by Deployment (2027-2032)
6.3.3 World Nuclear Medicine Software Market Size Market Share by Deployment (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Nuclear Medicine Software Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Image Acquisition and Reconstruction Software
7.2.2 Image Processing and Analysis Software
7.2.3 Reporting and Information Management Software
7.2.4 Others
7.3 Market Segment by Function
7.3.1 World Nuclear Medicine Software Market Size by Function (2021-2026)
7.3.2 World Nuclear Medicine Software Market Size by Function (2027-2032)
7.3.3 World Nuclear Medicine Software Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Nuclear Medicine Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Diagnosis
8.2.2 Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Nuclear Medicine Software Market Size by Application (2021-2026)
8.3.2 World Nuclear Medicine Software Market Size by Application (2027-2032)
8.3.3 World Nuclear Medicine Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 iQ IMAGE
9.1.1 iQ IMAGE Details
9.1.2 iQ IMAGE Major Business
9.1.3 iQ IMAGE Nuclear Medicine Software Product and Services
9.1.4 iQ IMAGE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 iQ IMAGE Recent Developments/Updates
9.1.6 iQ IMAGE Competitive Strengths & Weaknesses
9.2 Mediso
9.2.1 Mediso Details
9.2.2 Mediso Major Business
9.2.3 Mediso Nuclear Medicine Software Product and Services
9.2.4 Mediso Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mediso Recent Developments/Updates
9.2.6 Mediso Competitive Strengths & Weaknesses
9.3 Segami
9.3.1 Segami Details
9.3.2 Segami Major Business
9.3.3 Segami Nuclear Medicine Software Product and Services
9.3.4 Segami Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Segami Recent Developments/Updates
9.3.6 Segami Competitive Strengths & Weaknesses
9.4 Hermes Medical Solutions
9.4.1 Hermes Medical Solutions Details
9.4.2 Hermes Medical Solutions Major Business
9.4.3 Hermes Medical Solutions Nuclear Medicine Software Product and Services
9.4.4 Hermes Medical Solutions Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Hermes Medical Solutions Recent Developments/Updates
9.4.6 Hermes Medical Solutions Competitive Strengths & Weaknesses
9.5 MIM Software Inc
9.5.1 MIM Software Inc Details
9.5.2 MIM Software Inc Major Business
9.5.3 MIM Software Inc Nuclear Medicine Software Product and Services
9.5.4 MIM Software Inc Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MIM Software Inc Recent Developments/Updates
9.5.6 MIM Software Inc Competitive Strengths & Weaknesses
9.6 LabLogic
9.6.1 LabLogic Details
9.6.2 LabLogic Major Business
9.6.3 LabLogic Nuclear Medicine Software Product and Services
9.6.4 LabLogic Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 LabLogic Recent Developments/Updates
9.6.6 LabLogic Competitive Strengths & Weaknesses
9.7 scintido
9.7.1 scintido Details
9.7.2 scintido Major Business
9.7.3 scintido Nuclear Medicine Software Product and Services
9.7.4 scintido Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 scintido Recent Developments/Updates
9.7.6 scintido Competitive Strengths & Weaknesses
9.8 Gamma Gurus
9.8.1 Gamma Gurus Details
9.8.2 Gamma Gurus Major Business
9.8.3 Gamma Gurus Nuclear Medicine Software Product and Services
9.8.4 Gamma Gurus Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Gamma Gurus Recent Developments/Updates
9.8.6 Gamma Gurus Competitive Strengths & Weaknesses
9.9 Mirion Medical
9.9.1 Mirion Medical Details
9.9.2 Mirion Medical Major Business
9.9.3 Mirion Medical Nuclear Medicine Software Product and Services
9.9.4 Mirion Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Mirion Medical Recent Developments/Updates
9.9.6 Mirion Medical Competitive Strengths & Weaknesses
9.10 PAIRE
9.10.1 PAIRE Details
9.10.2 PAIRE Major Business
9.10.3 PAIRE Nuclear Medicine Software Product and Services
9.10.4 PAIRE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 PAIRE Recent Developments/Updates
9.10.6 PAIRE Competitive Strengths & Weaknesses
9.11 GE HealthCare
9.11.1 GE HealthCare Details
9.11.2 GE HealthCare Major Business
9.11.3 GE HealthCare Nuclear Medicine Software Product and Services
9.11.4 GE HealthCare Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GE HealthCare Recent Developments/Updates
9.11.6 GE HealthCare Competitive Strengths & Weaknesses
9.12 Inter Medical
9.12.1 Inter Medical Details
9.12.2 Inter Medical Major Business
9.12.3 Inter Medical Nuclear Medicine Software Product and Services
9.12.4 Inter Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Inter Medical Recent Developments/Updates
9.12.6 Inter Medical Competitive Strengths & Weaknesses
9.13 Sirona
9.13.1 Sirona Details
9.13.2 Sirona Major Business
9.13.3 Sirona Nuclear Medicine Software Product and Services
9.13.4 Sirona Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Sirona Recent Developments/Updates
9.13.6 Sirona Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Nuclear Medicine Software Industry Chain
10.2 Nuclear Medicine Software Upstream Analysis
10.3 Nuclear Medicine Software Midstream Analysis
10.4 Nuclear Medicine Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Nuclear Medicine Software Introduction
1.2 World Nuclear Medicine Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nuclear Medicine Software Total Market by Region (by Headquarter Location)
1.3.1 World Nuclear Medicine Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.3 China Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.4 Europe Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.5 Japan Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.6 South Korea Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Nuclear Medicine Software Revenue (2021-2032)
1.3.8 India Based Company Nuclear Medicine Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Software Consumption Value (2021-2032)
2.2 World Nuclear Medicine Software Consumption Value by Region
2.2.1 World Nuclear Medicine Software Consumption Value by Region (2021-2026)
2.2.2 World Nuclear Medicine Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Nuclear Medicine Software Consumption Value (2021-2032)
2.4 China Nuclear Medicine Software Consumption Value (2021-2032)
2.5 Europe Nuclear Medicine Software Consumption Value (2021-2032)
2.6 Japan Nuclear Medicine Software Consumption Value (2021-2032)
2.7 South Korea Nuclear Medicine Software Consumption Value (2021-2032)
2.8 ASEAN Nuclear Medicine Software Consumption Value (2021-2032)
2.9 India Nuclear Medicine Software Consumption Value (2021-2032)
3 WORLD NUCLEAR MEDICINE SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nuclear Medicine Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nuclear Medicine Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Nuclear Medicine Software in 2025
3.3 Nuclear Medicine Software Company Evaluation Quadrant
3.4 Nuclear Medicine Software Market: Overall Company Footprint Analysis
3.4.1 Nuclear Medicine Software Market: Region Footprint
3.4.2 Nuclear Medicine Software Market: Company Product Type Footprint
3.4.3 Nuclear Medicine Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nuclear Medicine Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nuclear Medicine Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nuclear Medicine Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nuclear Medicine Software Consumption Value Comparison
4.2.1 United States VS China: Nuclear Medicine Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nuclear Medicine Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nuclear Medicine Software Companies and Market Share, 2021-2026
4.3.1 United States Based Nuclear Medicine Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nuclear Medicine Software Revenue, (2021-2026)
4.4 China Based Companies Nuclear Medicine Software Revenue and Market Share, 2021-2026
4.4.1 China Based Nuclear Medicine Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nuclear Medicine Software Revenue, (2021-2026)
4.5 Rest of World Based Nuclear Medicine Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nuclear Medicine Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Drug Management
5.2.2 Radiation Management
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Software Market Size by Type (2021-2026)
5.3.2 World Nuclear Medicine Software Market Size by Type (2027-2032)
5.3.3 World Nuclear Medicine Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT
6.1 World Nuclear Medicine Software Market Size Overview by Deployment: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment
6.2.1 On Premise Software
6.2.2 Cloud-Based Software
6.3 Market Segment by Deployment
6.3.1 World Nuclear Medicine Software Market Size by Deployment (2021-2026)
6.3.2 World Nuclear Medicine Software Market Size by Deployment (2027-2032)
6.3.3 World Nuclear Medicine Software Market Size Market Share by Deployment (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Nuclear Medicine Software Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Image Acquisition and Reconstruction Software
7.2.2 Image Processing and Analysis Software
7.2.3 Reporting and Information Management Software
7.2.4 Others
7.3 Market Segment by Function
7.3.1 World Nuclear Medicine Software Market Size by Function (2021-2026)
7.3.2 World Nuclear Medicine Software Market Size by Function (2027-2032)
7.3.3 World Nuclear Medicine Software Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Nuclear Medicine Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Diagnosis
8.2.2 Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Nuclear Medicine Software Market Size by Application (2021-2026)
8.3.2 World Nuclear Medicine Software Market Size by Application (2027-2032)
8.3.3 World Nuclear Medicine Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 iQ IMAGE
9.1.1 iQ IMAGE Details
9.1.2 iQ IMAGE Major Business
9.1.3 iQ IMAGE Nuclear Medicine Software Product and Services
9.1.4 iQ IMAGE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 iQ IMAGE Recent Developments/Updates
9.1.6 iQ IMAGE Competitive Strengths & Weaknesses
9.2 Mediso
9.2.1 Mediso Details
9.2.2 Mediso Major Business
9.2.3 Mediso Nuclear Medicine Software Product and Services
9.2.4 Mediso Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mediso Recent Developments/Updates
9.2.6 Mediso Competitive Strengths & Weaknesses
9.3 Segami
9.3.1 Segami Details
9.3.2 Segami Major Business
9.3.3 Segami Nuclear Medicine Software Product and Services
9.3.4 Segami Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Segami Recent Developments/Updates
9.3.6 Segami Competitive Strengths & Weaknesses
9.4 Hermes Medical Solutions
9.4.1 Hermes Medical Solutions Details
9.4.2 Hermes Medical Solutions Major Business
9.4.3 Hermes Medical Solutions Nuclear Medicine Software Product and Services
9.4.4 Hermes Medical Solutions Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Hermes Medical Solutions Recent Developments/Updates
9.4.6 Hermes Medical Solutions Competitive Strengths & Weaknesses
9.5 MIM Software Inc
9.5.1 MIM Software Inc Details
9.5.2 MIM Software Inc Major Business
9.5.3 MIM Software Inc Nuclear Medicine Software Product and Services
9.5.4 MIM Software Inc Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MIM Software Inc Recent Developments/Updates
9.5.6 MIM Software Inc Competitive Strengths & Weaknesses
9.6 LabLogic
9.6.1 LabLogic Details
9.6.2 LabLogic Major Business
9.6.3 LabLogic Nuclear Medicine Software Product and Services
9.6.4 LabLogic Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 LabLogic Recent Developments/Updates
9.6.6 LabLogic Competitive Strengths & Weaknesses
9.7 scintido
9.7.1 scintido Details
9.7.2 scintido Major Business
9.7.3 scintido Nuclear Medicine Software Product and Services
9.7.4 scintido Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 scintido Recent Developments/Updates
9.7.6 scintido Competitive Strengths & Weaknesses
9.8 Gamma Gurus
9.8.1 Gamma Gurus Details
9.8.2 Gamma Gurus Major Business
9.8.3 Gamma Gurus Nuclear Medicine Software Product and Services
9.8.4 Gamma Gurus Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Gamma Gurus Recent Developments/Updates
9.8.6 Gamma Gurus Competitive Strengths & Weaknesses
9.9 Mirion Medical
9.9.1 Mirion Medical Details
9.9.2 Mirion Medical Major Business
9.9.3 Mirion Medical Nuclear Medicine Software Product and Services
9.9.4 Mirion Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Mirion Medical Recent Developments/Updates
9.9.6 Mirion Medical Competitive Strengths & Weaknesses
9.10 PAIRE
9.10.1 PAIRE Details
9.10.2 PAIRE Major Business
9.10.3 PAIRE Nuclear Medicine Software Product and Services
9.10.4 PAIRE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 PAIRE Recent Developments/Updates
9.10.6 PAIRE Competitive Strengths & Weaknesses
9.11 GE HealthCare
9.11.1 GE HealthCare Details
9.11.2 GE HealthCare Major Business
9.11.3 GE HealthCare Nuclear Medicine Software Product and Services
9.11.4 GE HealthCare Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GE HealthCare Recent Developments/Updates
9.11.6 GE HealthCare Competitive Strengths & Weaknesses
9.12 Inter Medical
9.12.1 Inter Medical Details
9.12.2 Inter Medical Major Business
9.12.3 Inter Medical Nuclear Medicine Software Product and Services
9.12.4 Inter Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Inter Medical Recent Developments/Updates
9.12.6 Inter Medical Competitive Strengths & Weaknesses
9.13 Sirona
9.13.1 Sirona Details
9.13.2 Sirona Major Business
9.13.3 Sirona Nuclear Medicine Software Product and Services
9.13.4 Sirona Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Sirona Recent Developments/Updates
9.13.6 Sirona Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Nuclear Medicine Software Industry Chain
10.2 Nuclear Medicine Software Upstream Analysis
10.3 Nuclear Medicine Software Midstream Analysis
10.4 Nuclear Medicine Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Medicine Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nuclear Medicine Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nuclear Medicine Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nuclear Medicine Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nuclear Medicine Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nuclear Medicine Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nuclear Medicine Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nuclear Medicine Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nuclear Medicine Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nuclear Medicine Software Players in 2025
Table 12. World Nuclear Medicine Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nuclear Medicine Software Company Evaluation Quadrant
Table 14. Head Office of Key Nuclear Medicine Software Players
Table 15. Nuclear Medicine Software Market: Company Product Type Footprint
Table 16. Nuclear Medicine Software Market: Company Product Application Footprint
Table 17. Nuclear Medicine Software Mergers & Acquisitions Activity
Table 18. United States VS China Nuclear Medicine Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nuclear Medicine Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nuclear Medicine Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nuclear Medicine Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 23. China Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nuclear Medicine Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nuclear Medicine Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 29. World Nuclear Medicine Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nuclear Medicine Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nuclear Medicine Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nuclear Medicine Software Market Size by Deployment, (USD Million), 2021 & 2025 & 2032
Table 33. World Nuclear Medicine Software Market Size Value by Deployment (2021-2026) & (USD Million)
Table 34. World Nuclear Medicine Software Market Size by Deployment (2027-2032) & (USD Million)
Table 35. World Nuclear Medicine Software Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Nuclear Medicine Software Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Nuclear Medicine Software Market Size by Function (2027-2032) & (USD Million)
Table 38. World Nuclear Medicine Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Nuclear Medicine Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Nuclear Medicine Software Market Size by Application (2027-2032) & (USD Million)
Table 41. iQ IMAGE Basic Information, Manufacturing Base and Competitors
Table 42. iQ IMAGE Major Business
Table 43. iQ IMAGE Nuclear Medicine Software Product and Services
Table 44. iQ IMAGE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. iQ IMAGE Recent Developments/Updates
Table 46. iQ IMAGE Competitive Strengths & Weaknesses
Table 47. Mediso Basic Information, Manufacturing Base and Competitors
Table 48. Mediso Major Business
Table 49. Mediso Nuclear Medicine Software Product and Services
Table 50. Mediso Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mediso Recent Developments/Updates
Table 52. Mediso Competitive Strengths & Weaknesses
Table 53. Segami Basic Information, Manufacturing Base and Competitors
Table 54. Segami Major Business
Table 55. Segami Nuclear Medicine Software Product and Services
Table 56. Segami Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Segami Recent Developments/Updates
Table 58. Segami Competitive Strengths & Weaknesses
Table 59. Hermes Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 60. Hermes Medical Solutions Major Business
Table 61. Hermes Medical Solutions Nuclear Medicine Software Product and Services
Table 62. Hermes Medical Solutions Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hermes Medical Solutions Recent Developments/Updates
Table 64. Hermes Medical Solutions Competitive Strengths & Weaknesses
Table 65. MIM Software Inc Basic Information, Manufacturing Base and Competitors
Table 66. MIM Software Inc Major Business
Table 67. MIM Software Inc Nuclear Medicine Software Product and Services
Table 68. MIM Software Inc Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MIM Software Inc Recent Developments/Updates
Table 70. MIM Software Inc Competitive Strengths & Weaknesses
Table 71. LabLogic Basic Information, Manufacturing Base and Competitors
Table 72. LabLogic Major Business
Table 73. LabLogic Nuclear Medicine Software Product and Services
Table 74. LabLogic Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LabLogic Recent Developments/Updates
Table 76. LabLogic Competitive Strengths & Weaknesses
Table 77. scintido Basic Information, Manufacturing Base and Competitors
Table 78. scintido Major Business
Table 79. scintido Nuclear Medicine Software Product and Services
Table 80. scintido Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. scintido Recent Developments/Updates
Table 82. scintido Competitive Strengths & Weaknesses
Table 83. Gamma Gurus Basic Information, Manufacturing Base and Competitors
Table 84. Gamma Gurus Major Business
Table 85. Gamma Gurus Nuclear Medicine Software Product and Services
Table 86. Gamma Gurus Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Gamma Gurus Recent Developments/Updates
Table 88. Gamma Gurus Competitive Strengths & Weaknesses
Table 89. Mirion Medical Basic Information, Manufacturing Base and Competitors
Table 90. Mirion Medical Major Business
Table 91. Mirion Medical Nuclear Medicine Software Product and Services
Table 92. Mirion Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Mirion Medical Recent Developments/Updates
Table 94. Mirion Medical Competitive Strengths & Weaknesses
Table 95. PAIRE Basic Information, Manufacturing Base and Competitors
Table 96. PAIRE Major Business
Table 97. PAIRE Nuclear Medicine Software Product and Services
Table 98. PAIRE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. PAIRE Recent Developments/Updates
Table 100. PAIRE Competitive Strengths & Weaknesses
Table 101. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 102. GE HealthCare Major Business
Table 103. GE HealthCare Nuclear Medicine Software Product and Services
Table 104. GE HealthCare Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GE HealthCare Recent Developments/Updates
Table 106. GE HealthCare Competitive Strengths & Weaknesses
Table 107. Inter Medical Basic Information, Manufacturing Base and Competitors
Table 108. Inter Medical Major Business
Table 109. Inter Medical Nuclear Medicine Software Product and Services
Table 110. Inter Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Inter Medical Recent Developments/Updates
Table 112. Inter Medical Competitive Strengths & Weaknesses
Table 113. Sirona Basic Information, Manufacturing Base and Competitors
Table 114. Sirona Major Business
Table 115. Sirona Nuclear Medicine Software Product and Services
Table 116. Sirona Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Sirona Recent Developments/Updates
Table 118. Sirona Competitive Strengths & Weaknesses
Table 119. Global Key Players of Nuclear Medicine Software Upstream (Raw Materials)
Table 120. Global Nuclear Medicine Software Typical Customers
Table 1. World Nuclear Medicine Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nuclear Medicine Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nuclear Medicine Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nuclear Medicine Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nuclear Medicine Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nuclear Medicine Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nuclear Medicine Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nuclear Medicine Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nuclear Medicine Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nuclear Medicine Software Players in 2025
Table 12. World Nuclear Medicine Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nuclear Medicine Software Company Evaluation Quadrant
Table 14. Head Office of Key Nuclear Medicine Software Players
Table 15. Nuclear Medicine Software Market: Company Product Type Footprint
Table 16. Nuclear Medicine Software Market: Company Product Application Footprint
Table 17. Nuclear Medicine Software Mergers & Acquisitions Activity
Table 18. United States VS China Nuclear Medicine Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nuclear Medicine Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nuclear Medicine Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nuclear Medicine Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 23. China Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nuclear Medicine Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nuclear Medicine Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nuclear Medicine Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nuclear Medicine Software Revenue Market Share (2021-2026)
Table 29. World Nuclear Medicine Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nuclear Medicine Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nuclear Medicine Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nuclear Medicine Software Market Size by Deployment, (USD Million), 2021 & 2025 & 2032
Table 33. World Nuclear Medicine Software Market Size Value by Deployment (2021-2026) & (USD Million)
Table 34. World Nuclear Medicine Software Market Size by Deployment (2027-2032) & (USD Million)
Table 35. World Nuclear Medicine Software Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Nuclear Medicine Software Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Nuclear Medicine Software Market Size by Function (2027-2032) & (USD Million)
Table 38. World Nuclear Medicine Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Nuclear Medicine Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Nuclear Medicine Software Market Size by Application (2027-2032) & (USD Million)
Table 41. iQ IMAGE Basic Information, Manufacturing Base and Competitors
Table 42. iQ IMAGE Major Business
Table 43. iQ IMAGE Nuclear Medicine Software Product and Services
Table 44. iQ IMAGE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. iQ IMAGE Recent Developments/Updates
Table 46. iQ IMAGE Competitive Strengths & Weaknesses
Table 47. Mediso Basic Information, Manufacturing Base and Competitors
Table 48. Mediso Major Business
Table 49. Mediso Nuclear Medicine Software Product and Services
Table 50. Mediso Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mediso Recent Developments/Updates
Table 52. Mediso Competitive Strengths & Weaknesses
Table 53. Segami Basic Information, Manufacturing Base and Competitors
Table 54. Segami Major Business
Table 55. Segami Nuclear Medicine Software Product and Services
Table 56. Segami Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Segami Recent Developments/Updates
Table 58. Segami Competitive Strengths & Weaknesses
Table 59. Hermes Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 60. Hermes Medical Solutions Major Business
Table 61. Hermes Medical Solutions Nuclear Medicine Software Product and Services
Table 62. Hermes Medical Solutions Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hermes Medical Solutions Recent Developments/Updates
Table 64. Hermes Medical Solutions Competitive Strengths & Weaknesses
Table 65. MIM Software Inc Basic Information, Manufacturing Base and Competitors
Table 66. MIM Software Inc Major Business
Table 67. MIM Software Inc Nuclear Medicine Software Product and Services
Table 68. MIM Software Inc Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MIM Software Inc Recent Developments/Updates
Table 70. MIM Software Inc Competitive Strengths & Weaknesses
Table 71. LabLogic Basic Information, Manufacturing Base and Competitors
Table 72. LabLogic Major Business
Table 73. LabLogic Nuclear Medicine Software Product and Services
Table 74. LabLogic Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LabLogic Recent Developments/Updates
Table 76. LabLogic Competitive Strengths & Weaknesses
Table 77. scintido Basic Information, Manufacturing Base and Competitors
Table 78. scintido Major Business
Table 79. scintido Nuclear Medicine Software Product and Services
Table 80. scintido Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. scintido Recent Developments/Updates
Table 82. scintido Competitive Strengths & Weaknesses
Table 83. Gamma Gurus Basic Information, Manufacturing Base and Competitors
Table 84. Gamma Gurus Major Business
Table 85. Gamma Gurus Nuclear Medicine Software Product and Services
Table 86. Gamma Gurus Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Gamma Gurus Recent Developments/Updates
Table 88. Gamma Gurus Competitive Strengths & Weaknesses
Table 89. Mirion Medical Basic Information, Manufacturing Base and Competitors
Table 90. Mirion Medical Major Business
Table 91. Mirion Medical Nuclear Medicine Software Product and Services
Table 92. Mirion Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Mirion Medical Recent Developments/Updates
Table 94. Mirion Medical Competitive Strengths & Weaknesses
Table 95. PAIRE Basic Information, Manufacturing Base and Competitors
Table 96. PAIRE Major Business
Table 97. PAIRE Nuclear Medicine Software Product and Services
Table 98. PAIRE Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. PAIRE Recent Developments/Updates
Table 100. PAIRE Competitive Strengths & Weaknesses
Table 101. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 102. GE HealthCare Major Business
Table 103. GE HealthCare Nuclear Medicine Software Product and Services
Table 104. GE HealthCare Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GE HealthCare Recent Developments/Updates
Table 106. GE HealthCare Competitive Strengths & Weaknesses
Table 107. Inter Medical Basic Information, Manufacturing Base and Competitors
Table 108. Inter Medical Major Business
Table 109. Inter Medical Nuclear Medicine Software Product and Services
Table 110. Inter Medical Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Inter Medical Recent Developments/Updates
Table 112. Inter Medical Competitive Strengths & Weaknesses
Table 113. Sirona Basic Information, Manufacturing Base and Competitors
Table 114. Sirona Major Business
Table 115. Sirona Nuclear Medicine Software Product and Services
Table 116. Sirona Nuclear Medicine Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Sirona Recent Developments/Updates
Table 118. Sirona Competitive Strengths & Weaknesses
Table 119. Global Key Players of Nuclear Medicine Software Upstream (Raw Materials)
Table 120. Global Nuclear Medicine Software Typical Customers
LIST OF FIGURES
Figure 1. Nuclear Medicine Software Picture
Figure 2. World Nuclear Medicine Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nuclear Medicine Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 13. Nuclear Medicine Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nuclear Medicine Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nuclear Medicine Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Software Markets in 2025
Figure 27. United States VS China: Nuclear Medicine Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nuclear Medicine Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nuclear Medicine Software Market Size Market Share by Type in 2025
Figure 31. Drug Management
Figure 32. Radiation Management
Figure 33. Other
Figure 34. World Nuclear Medicine Software Market Size Market Share by Type (2021-2032)
Figure 35. World Nuclear Medicine Software Market Size by Deployment, (USD Million), 2021 & 2025 & 2032
Figure 36. World Nuclear Medicine Software Market Size Market Share by Deployment in 2025
Figure 37. On Premise Software
Figure 38. Cloud-Based Software
Figure 39. World Nuclear Medicine Software Market Size Market Share by Deployment (2021-2032)
Figure 40. World Nuclear Medicine Software Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 41. World Nuclear Medicine Software Market Size Market Share by Function in 2025
Figure 42. Image Acquisition and Reconstruction Software
Figure 43. Image Processing and Analysis Software
Figure 44. Reporting and Information Management Software
Figure 45. Others
Figure 46. World Nuclear Medicine Software Market Size Market Share by Function (2021-2032)
Figure 47. World Nuclear Medicine Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Nuclear Medicine Software Market Size Market Share by Application in 2025
Figure 49. Clinical Diagnosis
Figure 50. Research
Figure 51. Others
Figure 52. World Nuclear Medicine Software Market Size Market Share by Application (2021-2032)
Figure 53. Nuclear Medicine Software Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Nuclear Medicine Software Picture
Figure 2. World Nuclear Medicine Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nuclear Medicine Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nuclear Medicine Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nuclear Medicine Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nuclear Medicine Software Revenue (2021-2032) & (USD Million)
Figure 13. Nuclear Medicine Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nuclear Medicine Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nuclear Medicine Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nuclear Medicine Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Software Markets in 2025
Figure 27. United States VS China: Nuclear Medicine Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nuclear Medicine Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nuclear Medicine Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nuclear Medicine Software Market Size Market Share by Type in 2025
Figure 31. Drug Management
Figure 32. Radiation Management
Figure 33. Other
Figure 34. World Nuclear Medicine Software Market Size Market Share by Type (2021-2032)
Figure 35. World Nuclear Medicine Software Market Size by Deployment, (USD Million), 2021 & 2025 & 2032
Figure 36. World Nuclear Medicine Software Market Size Market Share by Deployment in 2025
Figure 37. On Premise Software
Figure 38. Cloud-Based Software
Figure 39. World Nuclear Medicine Software Market Size Market Share by Deployment (2021-2032)
Figure 40. World Nuclear Medicine Software Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 41. World Nuclear Medicine Software Market Size Market Share by Function in 2025
Figure 42. Image Acquisition and Reconstruction Software
Figure 43. Image Processing and Analysis Software
Figure 44. Reporting and Information Management Software
Figure 45. Others
Figure 46. World Nuclear Medicine Software Market Size Market Share by Function (2021-2032)
Figure 47. World Nuclear Medicine Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Nuclear Medicine Software Market Size Market Share by Application in 2025
Figure 49. Clinical Diagnosis
Figure 50. Research
Figure 51. Others
Figure 52. World Nuclear Medicine Software Market Size Market Share by Application (2021-2032)
Figure 53. Nuclear Medicine Software Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
